Concert Pharmaceuticals
Why Robinhood?
You can watch CNCE and buy or sell other stocks, ETFs, and their options commission-free!About CNCE
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders.
CNCE Key Statistics
Stock Snapshot
Concert Pharmaceuticals(CNCE) stock is priced at $8.37, giving the company a market capitalization of 401.95M. It carries a P/E multiple of -2.61.
On 2026-05-23, Concert Pharmaceuticals(CNCE) stock opened at —, reached a high of —, and a low of —.
The Concert Pharmaceuticals(CNCE)'s current trading volume is 0, compared to an average daily volume of 2.51M.
During the past year, Concert Pharmaceuticals(CNCE) stock moved between $2.66 at its lowest and $8.55 at its peak.
During the past year, Concert Pharmaceuticals(CNCE) stock moved between $2.66 at its lowest and $8.55 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.